SMO1-3 is one of three Arabidopsis thaliana SMO1 isoforms (SMO1-1, SMO1-2, and SMO1-3) that catalyze the oxidation of 4α-methylsterols during phytosterol biosynthesis . These enzymes are essential for:
Embryo development: Double mutants (smo1-1 smo1-2) exhibit severe embryonic lethality due to disrupted auxin and cytokinin signaling .
Sterol homeostasis: SMO1 enzymes regulate cholesterol-like compounds critical for membrane integrity and hormone signaling .
Auxin-cytokinin crosstalk: Impaired SMO1 activity leads to elevated auxin responses and reduced cytokinin activity, perturbing cell differentiation .
| Isoform | Mutant Phenotype | Key Function |
|---|---|---|
| SMO1-1 | Lethal in homozygous smo1-1 smo1-2 mutants | Catalyzes sterol oxidation; maintains auxin-cytokinin balance |
| SMO1-2 | Embryonic lethality in double mutants | Required for sterol-dependent signaling pathways |
| SMO1-3 | Partially compensates for SMO1-1/SMO1-2 loss | Redundant role in sterol metabolism |
Sterol binding to Smoothened (SMO): While unrelated to the Hedgehog pathway’s SMO protein in animals , plant SMO1-3 indirectly influences lipid-mediated signaling by modulating sterol availability .
Gene redundancy: Single smo1-3 mutants show no visible defects, but combinatorial knockouts (e.g., smo1-1 smo1-2) are lethal, highlighting functional overlap .
Therapeutic potential: Antibodies targeting sterol-metabolizing enzymes (e.g., SMO1-3) could inform strategies for engineering stress-resistant crops .
Though the provided sources lack direct data on SMO1-3 antibody validation, analogous studies on plant antibodies emphasize:
KEGG: ath:AT4G22755
Here’s a structured FAQ collection for researchers working with SMO1-3 antibodies, optimized for academic rigor and methodological depth:
Framework:
Analysis Workflow:
Emerging Methods:
CITE-seq: Pair antibody-derived tags with transcriptomics to correlate protein localization with gene expression .
Live-Cell Imaging: Use pH-sensitive GFP fusions to track real-time antibody internalization .
Nanobody Engineering: Develop camelid-derived nanobodies for improved tissue penetration (e.g., PRL-3-targeting alpaca antibodies) .
Stepwise Approach:
Middle-Level LC-MS: Use FabRICATOR-digested fragments (23–25 kDa) for glycosylation profiling .
Redox-State Testing: Compare reducing vs. non-reducing SDS-PAGE to identify disulfide bond artifacts .
Temporal Analysis: Sample at multiple timepoints (0–24h post-stimulation) to capture dynamic modifications .